期刊
SPORTS MEDICINE
卷 41, 期 11, 页码 949-966出版社
ADIS INT LTD
DOI: 10.2165/11591430-000000000-00000
关键词
-
资金
- Intramural NIH HHS [Z01 DA000413-11, ZIA DA000413-12] Funding Source: Medline
- NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000414, ZIADA000413] Funding Source: NIH RePORTER
Since 2004, when the World Anti-Doping Agency assumed the responsibility for establishing and maintaining the list of prohibited substances and methods in sport (i.e. the Prohibited List), cannabinoids have been prohibited in all sports during competition. The basis for this prohibition can be found in the World Anti-Doping Code, which defines the three criteria used to consider banning a substance. In this context, we discuss the potential of cannabis to enhance sports performance, the risk it poses to the athlete's health and its violation of the spirit of sport. Although these compounds are prohibited in-competition only, we explain why the pharmacokinetics of their main psychoactive compound, Delta(9)-tetrahydrocannabinol, may complicate the results management of adverse analytical findings. Passive inhalation does not appear to be a plausible explanation for a positive test. Although the prohibition of cannabinoids in sports is one of the most controversial issues in anti-doping, in this review we stress the reasons behind this prohibition, with strong emphasis on the evolving knowledge of cannabinoid pharmacology.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据